外周性小脑上动脉动脉瘤的血管内治疗:现状与未来考量
结果显示81.8%以自发性蛛网膜下腔出血起病,83.6%预后良好,操作相关并发症发生率为34.7%,但无致命或严重长期并发症,提示血管内治疗安全有效。
要点
- 外周性小脑上动脉动脉瘤是不同于基底动脉-小脑上动脉交界处动脉瘤的独立病变。
- 血管内治疗外周性小脑上动脉动脉瘤预后良好率高,永久性及致命性操作并发症罕见。
- 仍需前瞻性大样本研究进一步明确血管内治疗在该病变中的地位。
核心结论
- 外周性小脑上动脉动脉瘤是罕见的脑血管病变,应作为独立实体对待。
- 血管内治疗是外周性小脑上动脉动脉瘤有效且安全的选择。
- 永久性和致命性操作相关并发症罕见。
研究设计与样本
- 于2019年2月13日检索PubMed英文文献,纳入接受血管内治疗的外周性小脑上动脉动脉瘤患者。
- 小脑上动脉分段依据Rodriguez-Hernandez等提出的命名法,改良Rankin量表评分≤1定义为恢复良好。
主要发现
- 患者年龄3个月至79岁(46.22 ± 13.51岁),女性28例(50.9%)。
- 46例(83.6%)恢复良好。
- 血管内治疗期间17/49例(34.7%)发生永久性或暂时性操作相关并发症。
- 长期随访中无致命或严重操作相关并发症。
临床怎么用
- 对外周性小脑上动脉动脉瘤可考虑血管内治疗,需注意操作相关并发症风险。
局限性
- 需进一步前瞻性、更大规模研究以更好阐明血管内治疗在外周性小脑上动脉动脉瘤中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Superior cerebellar artery (SCA) aneurysms can be divided into 2 types: basilar artery (BA)-SCA junction aneurysms and peripheral SCA aneurysms. The peripheral SCA aneurysm is a distinct entity from its BA-SCA counterpart. No comprehensive literature review for endovascular management of peripheral SCA aneurysms has been conducted. METHODS: A PubMed search of the published articles written in English was performed on February 13, 2019 for patients who underwent endovascular treatment for peripheral SCA aneurysms. Segmentation of SCA was in accordance with the proposed nomenclature by Rodriguez-Hernandez et al. A modified Rankin Scale score ≤1 was defined as good recovery. RESULTS: Thirty-five articles reporting 55 patients including 2 cases in our center were included in the final analysis. The affected patients (28 females, 50.9%) were aged from 3 months to 79 years (46.22 ± 13.51 years). Forty-five patients (81.8%) presented with spontaneous subarachnoid hemorrhage with or without cerebellar hematoma. Forty-six patients (83.6%) experienced good recovery. Permanent or transient procedure-related complications occurred in 17/49 patients (34.7%) during endovascular treatment (EVT). However, no fatal or server procedure-related complication occurred in the long-term. CONCLUSIONS: Peripheral SCA aneurysms are rare cerebrovascular lesions and should be treated as a specific entity. EVT is an efficient and safe option in peripheral SCA aneurysms. Permanent and fatal procedure-related complications are rare. Further prospective and larger-scale studies are warranted to better elucidate the role of EVT in peripheral SCA aneurysms.
引用
- Hou K, Li G, Wang X, et al. Endovascular Treatment for Peripheral Superior Cerebellar Artery Aneurysms: Current State and Future Considerations. World Neurosurg. 2019. PMID: 31028980. doi:10.1016/j.wneu.2019.04.145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。